Announced details
Infertility treatment, assisted reproductive technology (ART), identification of eggs, embryos and sperm, intracytoplasmic sperm injection (ICSI), human healthcare and reproductive medicine, and life sciences
The agreement states that the parties aim to shorten working hours and improve pregnancy and live birth rates, but numerical figures are Not disclosed
Business partnership to jointly develop and commercialize an AI system for the infertility treatment field. Capital and personnel relationships: Not disclosed.
Head office: Minato-ku, Tokyo; President and Representative Director: Kita Nobuo (喜多伸夫). A core operating company of the SIOS Group, whose holding company is SIOS Corporation (TSE Standard: 3744). It develops and sells software products using cloud computing, AI and other technologies, and provides system integration services. The SIOS Group was established in 1997.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Infertility treatment support system using cutting-edge AI technology |
| Counterparty | サイオステクノロジー株式会社 |
| Counterparty overview | Head office: Minato-ku, Tokyo; President and Representative Director: Kita Nobuo (喜多伸夫). A core operating company of the SIOS Group, whose holding company is SIOS Corporation (TSE Standard: 3744). It develops and sells software products using cloud computing, AI and other technologies, and provides system integration services. The SIOS Group was established in 1997. |
| Relationship with the Company | Business partnership to jointly develop and commercialize an AI system for the infertility treatment field. Capital and personnel relationships: Not disclosed. |
| Contract Date | 3 August 2026 |
| Applicable area | Infertility treatment, assisted reproductive technology (ART), identification of eggs, embryos and sperm, intracytoplasmic sperm injection (ICSI), human healthcare and reproductive medicine, and life sciences |
| Quantitative Effects | The agreement states that the parties aim to shorten working hours and improve pregnancy and live birth rates, but numerical figures are Not disclosed |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The partnership aims to address the reliance on experienced practitioners in the evaluation of eggs and embryos and the selection of sperm in infertility treatment, support the work of medical professionals, shorten working hours, improve pregnancy and live birth rates, and codify and standardize the relevant expertise.